The Phase 2 clinical trial is a single arm, multicenter study to evaluate the safety and efficacy of treatment with CoFactor plus 5-fluorouracil (5-FU) in advanced breast cancer patients who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback